Killer yeast

Last updated

A killer yeast is a yeast, such as Saccharomyces cerevisiae , which is able to secrete one of a number of toxic proteins which are lethal to susceptible cells. [1] These "killer toxins" are polypeptides that kill sensitive cells of the same or related species, often functioning by creating pores in target cell membranes. These yeast cells are immune to the toxic effects of the protein due to an intrinsic immunity. [2] Killer yeast strains can be a problem in commercial processing because they can kill desirable strains. [3] The killer yeast system was first described in 1963. [4] Study of killer toxins helped to better understand the secretion pathway of yeast, which is similar to those of more complex eukaryotes. It also can be used in treatment of some diseases, mainly those caused by fungi.

Contents

Saccharomyces cerevisiae

The best characterized toxin system is from yeast ( Saccharomyces cerevisiae ), which was found to spoil brewing of beer. In S. cerevisiae are toxins encoded by a double-stranded RNA virus, translated to a precursor protein, cleaved and secreted outside of the cells, where they may affect susceptible yeast. There are other killer systems in S. cerevisiae, such as KHR1 [5] and KHS1 [6] genes encoded on chromosomes IX and V, respectively.

RNA virus

The virus, L-A, is an icosahedral virus of S. cerevisiae comprising a 4.6 kb genomic segment and several satellite double-stranded RNA sequences, called M dsRNAs. The genomic segment encodes for the viral coat protein and a protein which replicates the viral genomes. [7] The M dsRNAs encode the toxin, of which there are at least three variants in S. cerevisiae, [2] [8] and many more variants across all species. [1] [9]

L-A virus uses yeast Ski complex (super killer) and MAK (maintenance of killer) chromosomal genes for its preservation in the cell. The virus is not released into the environment. It spreads between cells during yeast mating. [8] The family of Totiviridae in general helps M-type dsRNAs in a wide variety of yeasts. [10]

Toxins

The K1 preprotoxin, showing the a and b chains which make up the K1 toxin. The numbers count amino acid residues. K1 preprotoxin.jpg
The K1 preprotoxin, showing the α and β chains which make up the K1 toxin. The numbers count amino acid residues.

The initial protein product from translation of the M dsRNA is called the preprotoxin, which is targeted to the yeast secretory pathway. The preprotoxin is processed and cleaved to produce an α/β dimer, which is the active form of the toxin, and is released into the environment. [2] [11]

The two most studied variant toxins in S. cerevisiae are K1 and K28. There are numerous appearently unrelated M dsRNAs, their only similarity being their genome and preprotoxin organization. [10]

K1 binds to the β-1,6-D-glucan receptor on the target cell wall, moves inside, and then binds to the plasma membrane receptor Kre1p. It forms a cation-selective ion channel in the membrane, which is lethal to the cell. [11] [12]

K28 uses the α-1,6-mannoprotein receptor to enter the cell, and utilizes the secretory pathway in reverse by displaying the endoplasmic reticulum HDEL signal. From the ER, K28 moves into the cytoplasm and shuts down DNA synthesis in the nucleus, triggering apoptosis. [13] [14]


Immunity

Sesti, Shih, Nikolaeva and Goldstein (2001) claimed that K1 inhibits the TOK1 membrane potassium channel before secretion, and although the toxin reenters through the cell wall it is unable to reactivate TOK1. [15] However Breinig, Tipper and Schmitt (2002) showed that the TOK1 channel was not the primary receptor for K1, and that TOK1 inhibition does not confer immunity. [12] Vališ, Mašek, Novotná, Pospíšek and Janderová (2006) experimented with mutants which produce K1 but do not have immunity to it, and suggested that cell membrane receptors were being degraded in the secretion pathway of immune cells, apparently due to the actions of unprocessed α chains. [16] [17]

The K28 preprotoxin forms a complex with the K28 a/b dimer, neutralizing it. K28 Immunity.jpg
The K28 preprotoxin forms a complex with the K28 α/β dimer, neutralizing it.

Breinig, Sendzik, Eisfeld and Schmitt (2006) showed that K28 toxin is neutralized in toxin-expressing cells by the α chain in the cytosol, which has not yet been fully processed and still contains part of a γ chain attached to the C terminus. The uncleaved α chain neutralizes the K28 toxin by forming a complex with it. [2]

Kluyveromyces lactis

Killer properties of Kluyveromyces lactis are associated with linear DNA plasmids, which have on their 5'end associated proteins, which enable them to replicate themselves, in a way similar to adenoviruses. It is an example of protein priming in DNA replication. MAK genes are not known. The toxin consists of three subunits, which are matured in golgi complex by signal peptidase and glycosylated.

The mechanism of action appears to be the inhibition of adenylate cyclase in sensitive cells. Affected cells are arrested in G1 phase and lose viability.

Other yeast

Other toxin systems are found in other yeasts:

Use of toxins

The susceptibility to toxins varies greatly between yeast species and strains. Several experiments have made use of this to reliably identify strains. Morace, Archibusacci, Sestito and Polonelli (1984) used the toxins produced by 25 species of yeasts to differentiate between 112 pathogenic strains, based on their sensitivity to each toxin. [18] This was extended by Morace et al. (1989) to use toxins to differentiate between 58 bacterial cultures. [19] Vaughan-Martini, Cardinali and Martini (1996) used 24 strains of killer yeast from 13 species to find a resistance signature for each of 13 strains of S. cerevisiae which were used as starters in wine-making. [20] It was shown that sensitivity to toxins could be used to discriminate between 91 strains of Candida albicans and 223 other Candida strains. [21]

Others experimented with using killer yeasts to control undesirable yeasts. Palpacelli, Ciani and Rosini (1991) found that Kluyveromyces phaffii was effective against Kloeckera apiculata , Saccharomycodes ludwigii and Zygosaccharomyces rouxii – all of which cause problems in the food industry. [22] Polonelli et al. (1994) used a killer yeast to vaccinate against C. albicans in rats. [23] Lowes et al. (2000) created a synthetic gene for the toxin HMK normally produced by Williopsis mrakii , which they inserted into Aspergillus niger and showed that the engineered strain could control aerobic spoilage in maize silage and yoghurt. [24] A toxin-producing strain of Kluyveromyces phaffii to control apiculate yeasts in wine-making. [25] A toxin produced by Candida nodaensis was effective at preventing spoilage of highly salted food by yeasts. [26]

Several experiments suggest that antibodies that mimic the biological activity of killer toxins have application as antifungal agents. [27]

Killer yeasts from flowers of Indian medicinal plants were isolated and the effect of their killer toxin was determined on sensitive yeast cells as well as fungal pathogens. The toxin of Saccharomyces cerevisiae and Pichia kluyveri inhibited Dekkera anomala accumulating methylene blue cells on Yeast Extract Peptone Dextrose agar (pH 4.2) at 21°C. There was no inhibition of growth or competition between the yeast cells in the mixed population of S. cerevisiae isolated from Acalypha indica. S. cerevisiae and P. kluyveri were found to tolerate 50% and 40% glucose, while D. anomala tolerated 40% glucose. Both S. cerevisiae and P. kluyveri did not inhibit the growth of Aspergillus niger. [28]

Control methods

Young and Yagiu (1978) experimented with methods of curing killer yeasts. They found that using a cycloheximine solution at 0.05 ppm was effective in eliminating killer activity in one strain of S. cerevisiae. Incubating the yeast at 37 °C eliminated activity in another strain. The methods were not effective at reducing toxin production in other yeast species. [1] Many toxins are sensitive to pH levels; for example, K1 is permanently inactivated at pH levels over 6.5. [9]

The greatest potential for control of killer yeasts appears to be the addition of the L-A virus and M dsRNA, or an equivalent gene, into the industrially desirable variants of yeast, so they achieve immunity to the toxin, and also kill competing strains. [3]

See also

Related Research Articles

<span class="mw-page-title-main">Yeast</span> Informal group of fungi

Yeasts are eukaryotic, single-celled microorganisms classified as members of the fungus kingdom. The first yeast originated hundreds of millions of years ago, and at least 1,500 species are currently recognized. They are estimated to constitute 1% of all described fungal species.

<i>Saccharomyces cerevisiae</i> Species of yeast

Saccharomyces cerevisiae is a species of yeast. The species has been instrumental in winemaking, baking, and brewing since ancient times. It is believed to have been originally isolated from the skin of grapes. It is one of the most intensively studied eukaryotic model organisms in molecular and cell biology, much like Escherichia coli as the model bacterium. It is the microorganism behind the most common type of fermentation. S. cerevisiae cells are round to ovoid, 5–10 μm in diameter. It reproduces by budding.

<i>Candida albicans</i> Species of fungus

Candida albicans is an opportunistic pathogenic yeast that is a common member of the human gut flora. It can also survive outside the human body. It is detected in the gastrointestinal tract and mouth in 40–60% of healthy adults. It is usually a commensal organism, but it can become pathogenic in immunocompromised individuals under a variety of conditions. It is one of the few species of the genus Candida that cause the human infection candidiasis, which results from an overgrowth of the fungus. Candidiasis is, for example, often observed in HIV-infected patients. C. albicans is the most common fungal species isolated from biofilms either formed on (permanent) implanted medical devices or on human tissue. C. albicans, C. tropicalis, C. parapsilosis, and C. glabrata are together responsible for 50–90% of all cases of candidiasis in humans. A mortality rate of 40% has been reported for patients with systemic candidiasis due to C. albicans. By one estimate, invasive candidiasis contracted in a hospital causes 2,800 to 11,200 deaths yearly in the US. Nevertheless, these numbers may not truly reflect the true extent of damage this organism causes, given new studies indicating that C. albicans can cross the blood–brain barrier in mice.

<span class="mw-page-title-main">Transformation (genetics)</span> Genetic alteration of a cell by uptake of genetic material from the environment

In molecular biology and genetics, transformation is the genetic alteration of a cell resulting from the direct uptake and incorporation of exogenous genetic material from its surroundings through the cell membrane(s). For transformation to take place, the recipient bacterium must be in a state of competence, which might occur in nature as a time-limited response to environmental conditions such as starvation and cell density, and may also be induced in a laboratory.

<span class="mw-page-title-main">Satellite (biology)</span> Subviral agent which depends on a helper virus for its replication

A satellite is a subviral agent that depends on the coinfection of a host cell with a helper virus for its replication. Satellites can be divided into two major classes: satellite viruses and satellite nucleic acids. Satellite viruses, which are most commonly associated with plants, are also found in mammals, arthropods, and bacteria. They encode structural proteins to enclose their genetic material, which are therefore distinct from the structural proteins of their helper viruses. Satellite nucleic acids, in contrast, do not encode their own structural proteins, but instead are encapsulated by proteins encoded by their helper viruses. The genomes of satellites range upward from 359 nucleotides in length for satellite tobacco ringspot virus RNA (STobRV).

<i>Totiviridae</i> Family of viruses

Totiviridae is a family of double-stranded RNA viruses. Giardia lamblia, leishmania, trichomonas vaginalis, and fungi serve as natural hosts. The name of the group derives from Latin toti which means undivided or whole. There are 28 species in this family, assigned to 5 genera.

<span class="mw-page-title-main">CRISPR</span> Family of DNA sequence found in prokaryotic organisms

CRISPR is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to detect and destroy DNA from similar bacteriophages during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes and provide a form of acquired immunity. CRISPR is found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.

<i>Saccharomyces boulardii</i> Species of fungus

Saccharomyces boulardii is a tropical yeast first isolated from lychee and mangosteen fruit peel in 1923 by French scientist Henri Boulard. Although early reports claimed distinct taxonomic, metabolic, and genetic properties, S. boulardii is genetically a grouping of S. cerevisiae strains, sharing >99% genomic relatedness, giving the synonym S. cerevisiae var. boulardii.

<i>Kluyveromyces marxianus</i> Species of fungus

Kluyveromyces marxianus in ascomycetous yeast and member of the genus, Kluyveromyces. It is the sexual stage of Atelosaccharomyces pseudotropicalis also known as Candida kefyr. This species has a homothallic mating system and is often isolated from dairy products.

The Crabtree effect, named after the English biochemist Herbert Grace Crabtree, describes the phenomenon whereby the yeast, Saccharomyces cerevisiae, produces ethanol (alcohol) in aerobic conditions at high external glucose concentrations rather than producing biomass via the tricarboxylic acid (TCA) cycle, the usual process occurring aerobically in most yeasts e.g. Kluyveromyces spp. This phenomenon is observed in most species of the Saccharomyces, Schizosaccharomyces, Debaryomyces, Brettanomyces, Torulopsis, Nematospora, and Nadsonia genera. Increasing concentrations of glucose accelerates glycolysis which results in the production of appreciable amounts of ATP through substrate-level phosphorylation. This reduces the need of oxidative phosphorylation done by the TCA cycle via the electron transport chain and therefore decreases oxygen consumption. The phenomenon is believed to have evolved as a competition mechanism around the time when the first fruits on Earth fell from the trees. The Crabtree effect works by repressing respiration by the fermentation pathway, dependent on the substrate.

Cell wall protein 2 (CWP2) is a cell wall protein, produced by Saccharomyces cerevisiae and Saccharomyces pastorianus. It occurs throughout the cell wall and has close homology with the CWP1 gene.

A yeast expression platform is a strain of yeast used to produce large amounts of proteins, sugars or other compounds for research or industrial uses. While yeast are often more resource-intensive to maintain than bacteria, certain products can only be produced by eukaryotic cells like yeast, necessitating use of a yeast expression platform. Yeasts differ in productivity and with respect to their capabilities to secrete, process and modify proteins. As such, different types of yeast are better suited for different research and industrial applications.

Lachancea kluyveri is an ascomycetous yeast associated with fruit flies, slime fluxes, soils and foods.

Anti-Saccharomyces cerevisiae antibodies (ASCAs) are antibodies against antigens presented by the cell wall of the yeast Saccharomyces cerevisiae. These antibodies are directed against oligomannose sequences α-1,3 Man n. ASCAs and perinuclear antineutrophil cytoplasmic antibodies (pANCAs) are the two most useful and often discriminating biomarkers for colitis. ASCA tends to recognize Crohn's disease more frequently, whereas pANCA tend to recognize ulcerative colitis.

<span class="mw-page-title-main">Double-stranded RNA viruses</span> Type of virus according to Baltimore classification

Double-stranded RNA viruses are a polyphyletic group of viruses that have double-stranded genomes made of ribonucleic acid. The double-stranded genome is used as a template by the viral RNA-dependent RNA polymerase (RdRp) to transcribe a positive-strand RNA functioning as messenger RNA (mRNA) for the host cell's ribosomes, which translate it into viral proteins. The positive-strand RNA can also be replicated by the RdRp to create a new double-stranded viral genome.

Microbial toxins are toxins produced by micro-organisms, including bacteria, fungi, protozoa, dinoflagellates, and viruses. Many microbial toxins promote infection and disease by directly damaging host tissues and by disabling the immune system. Endotoxins most commonly refer to the lipopolysaccharide (LPS) or lipooligosaccharide (LOS) that are in the outer plasma membrane of Gram-negative bacteria. The botulinum toxin, which is primarily produced by Clostridium botulinum and less frequently by other Clostridium species, is the most toxic substance known in the world. However, microbial toxins also have important uses in medical science and research. Currently, new methods of detecting bacterial toxins are being developed to better isolate and understand these toxins. Potential applications of toxin research include combating microbial virulence, the development of novel anticancer drugs and other medicines, and the use of toxins as tools in neurobiology and cellular biology.

<span class="mw-page-title-main">BZIP intron RNA motif</span>

The bZIP intron RNA motif is an RNA structure guiding splicing of a non-canonical intron from bZIP-containing genes called HAC1 in yeast, XBP1 in Metazoa, Hxl1 or Cib1 in Basidiomycota and bZIP60 in plants. Splicing is performed independently of the spliceosome by Ire1, a kinase with endoribonuclease activity. Exons are joined by a tRNA ligase. Recognition of the intron splice sites is mediated by a base-paired secondary structure of the mRNA that forms at the exon/intron boundaries. Splicing of the bZIP intron is a key regulatory step in the unfolded protein response (UPR). The Ire-mediated unconventional splicing was first described for HAC1 in S. cerevisiae.

<span class="mw-page-title-main">Pdr1p</span>

Pdr1p is a transcription factor found in yeast and is a key regulator of genes involved in general drug response. It induces the expression of ATP-binding cassette transporter, which can export toxic substances out of the cell, allowing cells to survive under general toxic chemicals. It binds to DNA sequences that contain certain motifs called pleiotropic drug response element (PDRE). Pdr1p is encoded by a gene called PDR1 on chromosome VII.

<span class="mw-page-title-main">Bernard Dujon</span> French geneticist

Bernard Dujon is a French geneticist, born on August 8, 1947, in Meudon (Hauts-de-Seine). He is Professor Emeritus at Sorbonne University and the Institut Pasteur since 2015. He is a member of the French Academy of sciences.

<i>Saccharomyces cerevisiae virus L-A</i> Species of virus

Saccharomyces cerevisiae virus L-A, also called L-A helper virus, is a member of the Totiviridae family of viruses found primarily in Saccharomyces cerevisiae. Its discovery in the 1970s was the main starting point of research on yeast virology. It is a ~4.6 kb double-stranded RNA virus with no extracellular phase and so is inherited through vertical cytoplasmic transmission.

References

  1. 1 2 3 Young TW, Yagiu M (1978). "A comparison of the killer character in different yeasts and its classification". Antonie van Leeuwenhoek. 44 (1): 59–77. doi:10.1007/BF00400077. PMID   655699. S2CID   20931283.
  2. 1 2 3 4 Breinig F, Sendzik T, Eisfeld K, Schmitt MJ (March 2006). "Dissecting toxin immunity in virus-infected killer yeast uncovers an intrinsic strategy of self-protection". Proceedings of the National Academy of Sciences of the United States of America. 103 (10): 3810–5. Bibcode:2006PNAS..103.3810B. doi: 10.1073/pnas.0510070103 . PMC   1533781 . PMID   16505373.
  3. 1 2 Wickner RB (1986). "Double-stranded RNA replication in yeast: the killer system". Annual Review of Biochemistry. 55: 373–95. doi:10.1146/annurev.bi.55.070186.002105. PMID   3527047.
  4. ↑ Bevan, E. A., and M. Makower. (1963). "The physiological basis of the killer character in yeast". Proc. XIth Int. Congr. Genet. 1:202–203.
  5. ↑ Goto K, Iwatuki Y, Kitano K, Obata T, Hara S (April 1990). "Cloning and nucleotide sequence of the KHR killer gene of Saccharomyces cerevisiae". Agricultural and Biological Chemistry. 54 (4): 979–84. doi: 10.1271/bbb1961.54.979 . PMID   1368554.
  6. ↑ Goto K, Fukuda H, Kichise K, Kitano K, Hara S (August 1991). "Cloning and nucleotide sequence of the KHS killer gene of Saccharomyces cerevisiae". Agricultural and Biological Chemistry. 55 (8): 1953–8. doi: 10.1271/bbb1961.55.1953 . PMID   1368726.
  7. ↑ Ribas JC, Wickner RB (April 1998). "The Gag domain of the Gag-Pol fusion protein directs incorporation into the L-A double-stranded RNA viral particles in Saccharomyces cerevisiae". The Journal of Biological Chemistry. 273 (15): 9306–11. doi: 10.1074/jbc.273.15.9306 . PMID   9535925.
  8. 1 2 Wickner RB, Tang J, Gardner NA, Johnson JE (2008). "The Yeast dsRNA Virus L-A Resembles Mammalian dsRNA Virus Cores". In Patton JT (ed.). Segmented Double-stranded RNA Viruses: Structure and Molecular Biology. Caister Academic Press. p. 105. ISBN   978-1-904455-21-9. Archived from the original on 2022-02-01. Retrieved 2022-02-01.
  9. 1 2 Tipper DJ, Bostian KA (June 1984). "Double-stranded ribonucleic acid killer systems in yeasts". Microbiological Reviews. 48 (2): 125–56. doi:10.1128/MMBR.48.2.125-156.1984. PMC   373216 . PMID   6377033.
  10. 1 2 Ramírez, M; Velázquez, R; López-Piñeiro, A; Naranjo, B; Roig, F; Llorens, C (19 September 2017). "New Insights into the Genome Organization of Yeast Killer Viruses Based on "Atypical" Killer Strains Characterized by High-Throughput Sequencing". Toxins. 9 (9): 292. doi: 10.3390/toxins9090292 . PMC   5618225 . PMID   28925975.
  11. 1 2 Bussey H (October 1991). "K1 killer toxin, a pore-forming protein from yeast". Molecular Microbiology. 5 (10): 2339–43. doi:10.1111/j.1365-2958.1991.tb02079.x. PMID   1724277. S2CID   35664912.
  12. 1 2 Breinig F, Tipper DJ, Schmitt MJ (February 2002). "Kre1p, the plasma membrane receptor for the yeast K1 viral toxin". Cell. 108 (3): 395–405. doi: 10.1016/S0092-8674(02)00634-7 . PMID   11853673. S2CID   16889563.
  13. ↑ Reiter J, Herker E, Madeo F, Schmitt MJ (January 2005). "Viral killer toxins induce caspase-mediated apoptosis in yeast". The Journal of Cell Biology. 168 (3): 353–8. doi:10.1083/jcb.200408071. PMC   2171720 . PMID   15668299.
  14. ↑ Eisfeld K, Riffer F, Mentges J, Schmitt MJ (August 2000). "Endocytotic uptake and retrograde transport of a virally encoded killer toxin in yeast". Molecular Microbiology. 37 (4): 926–40. doi: 10.1046/j.1365-2958.2000.02063.x . PMID   10972812.
  15. ↑ Sesti F, Shih TM, Nikolaeva N, Goldstein SA (June 2001). "Immunity to K1 killer toxin: internal TOK1 blockade". Cell. 105 (5): 637–44. doi: 10.1016/S0092-8674(01)00376-2 . PMID   11389833. S2CID   16673130.
  16. ↑ Valis K, Masek T, Novotná D, Pospísek M, Janderová B (2006). "Immunity to killer toxin K1 is connected with the Golgi-to-vacuole protein degradation pathway". Folia Microbiologica. 51 (3): 196–202. doi:10.1007/BF02932122. PMID   17004650. S2CID   22496847.
  17. ↑ Sturley SL, Elliot Q, LeVitre J, Tipper DJ, Bostian KA (December 1986). "Mapping of functional domains within the Saccharomyces cerevisiae type 1 killer preprotoxin". The EMBO Journal. 5 (12): 3381–9. doi:10.1002/j.1460-2075.1986.tb04654.x. PMC   1167337 . PMID   3545818.
  18. ↑ Morace G, Archibusacci C, Sestito M, Polonelli L (February 1984). "Strain differentiation of pathogenic yeasts by the killer system". Mycopathologia. 84 (2–3): 81–5. doi:10.1007/BF00436517. PMID   6371541. S2CID   27061681.
  19. ↑ Morace G, Manzara S, Dettori G, Fanti F, Conti S, Campani L, et al. (September 1989). "Biotyping of bacterial isolates using the yeast killer system". European Journal of Epidemiology. 5 (3): 303–10. doi:10.1007/BF00144830. PMID   2676582. S2CID   30871936.
  20. ↑ Vaughan-Martini A, Cardinali G, Martini A (August 1996). "Differential killer sensitivity as a tool for fingerprinting wine-yeast strains of Saccharomyces cerevisiae". Journal of Industrial Microbiology. 17 (2): 124–7. doi: 10.1007/BF01570055 . PMID   8987896. S2CID   11095134.
  21. ↑ Buzzini P, Martini A (September 2001). "Discrimination between Candida albicans and other pathogenic species of the genus Candida by their differential sensitivities to toxins of a panel of killer yeasts". Journal of Clinical Microbiology. 39 (9): 3362–4. doi:10.1128/JCM.39.9.3362-3364.2001. PMC   88347 . PMID   11526179.
  22. ↑ Palpacelli V, Ciani M, Rosini G (November 1991). "Activity of different 'killer' yeasts on strains of yeast species undesirable in the food industry". FEMS Microbiology Letters. 68 (1): 75–8. doi: 10.1111/j.1574-6968.1991.tb04572.x . PMID   1769559.
  23. ↑ Polonelli L, De Bernardis F, Conti S, Boccanera M, Gerloni M, Morace G, et al. (March 1994). "Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies". Journal of Immunology. 152 (6): 3175–82. PMID   8144911. Archived from the original on 2022-02-01. Retrieved 2009-10-23.
  24. ↑ Lowes KF, Shearman CA, Payne J, MacKenzie D, Archer DB, Merry RJ, Gasson MJ (March 2000). "Prevention of yeast spoilage in feed and food by the yeast mycocin HMK". Applied and Environmental Microbiology. 66 (3): 1066–76. Bibcode:2000ApEnM..66.1066L. doi:10.1128/AEM.66.3.1066-1076.2000. PMC   91944 . PMID   10698773.
  25. ↑ Ciani M, Fatichenti F (July 2001). "Killer toxin of Kluyveromyces phaffii DBVPG 6076 as a biopreservative agent to control apiculate wine Yeasts". Applied and Environmental Microbiology. 67 (7): 3058–63. Bibcode:2001ApEnM..67.3058C. doi:10.1128/AEM.67.7.3058-3063.2001. PMC   92981 . PMID   11425722.
  26. ↑ da Silva S, Calado S, Lucas C, Aguiar C (2008). "Unusual properties of the halotolerant yeast Candida nodaensis Killer toxin, CnKT". Microbiological Research. 163 (2): 243–51. doi:10.1016/j.micres.2007.04.002. PMID   17761407.
  27. ↑ Magliani W, Conti S, Salati A, Vaccari S, Ravanetti L, Maffei DL, Polonelli L (October 2004). "Therapeutic potential of yeast killer toxin-like antibodies and mimotopes". FEMS Yeast Research. 5 (1): 11–8. doi: 10.1016/j.femsyr.2004.06.010 . PMID   15381118.
  28. ↑
    • Madhusudan P Dabhole and Dr K N Joishy. Production and effect of killer toxin by Saccharomyces cerevisiae and Pichia kluyveri on sensitive yeasts and fungal pathogens, Indian Journal of Biotechnology, 4(2),2005.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.